Explore /
Poster
/ Outcomes of patients with t(11;14) multiple myeloma: An international myeloma working group (IMWG) multicenter study.

Outcomes of patients with t(11;14) multiple myeloma: An international myeloma working group (IMWG) multicenter study.

Authors

Brian G. Durie

Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA

Brian G. Durie , Hartmut Goldschmidt , Maria-Victoria Mateos , Veronica Gonzalez , Juan Du , Kihyun Kim , Giampaolo Merlini , Silvia Mangiacavalli , Chang Ki Min , Meletios A. Dimopoulos , Efstathios Kastritis , Heinz Ludwig , Graca Esteves , Hiroshi Handa , Fernando Escalante , Carlos Fernández de Larrea Rodríguez , Michel Delforge , Chris Cameron , S. Vincent Rajkumar , Shaji Kumar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Plasma Cell Dyscrasia

Track

Hematologic Malignancies—Plasma Cell Dyscrasia

Sub Track

Multiple Myeloma

Citation

J Clin Oncol 37, 2019 (suppl; abstr 8015)

DOI

10.1200/JCO.2019.37.15_suppl.8015

Abstract #

8015

Poster Bd #

341

Abstract Disclosures

Similar Posters

Poster

2015 ASCO Annual Meeting

$Phase 1b interim results: Venetoclax (ABT-199/GDC-0199) in combination with bortezomib (BTZ) and dexamethasone (Dex) in relapsed/refractory (R/R) multiple myeloma (MM).$